Relmada Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Relmada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Relmada Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Relmada Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.2k | 540 | 4.14 |
| 2023-09-30 | $1.6k | 530 | 3.00 |
| 2023-06-30 | $1.3k | 534 | 2.46 |
| 2022-12-31 | $4.0k | 1.1k | 3.49 |
| 2022-09-30 | $2.5M | 67k | 37.74 |
| 2022-06-30 | $882k | 45k | 19.58 |
| 2022-03-31 | $658k | 24k | 27.13 |
| 2021-12-31 | $189k | 8.4k | 22.54 |
| 2021-09-30 | $33k | 1.3k | 25.92 |
| 2021-06-30 | $306k | 9.5k | 32.06 |
| 2021-03-31 | $434k | 12k | 35.24 |
| 2020-12-31 | $1.4M | 43k | 32.03 |
| 2020-09-30 | $1.3M | 35k | 37.60 |
| 2020-06-30 | $1.7M | 39k | 44.79 |
| 2020-03-31 | $398k | 12k | 34.08 |
| 2019-12-31 | $395k | 10k | 38.91 |